For example, it has been reported that KEAP1 alterations often co-occur with STK11 (serine/threonine kinase 11) and KRAS mutations in LUAD; likewise, NFE2L2 and TP53 co-mutations but in lung squamous cell carcinoma (LUSC) [50]. Here, STK11 is linked to squamous cell lung carcinoma.